Tammi L. Gaskins

CIK: 0002061679

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IRWD

IRONWOOD PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

IRWD
IRONWOOD PHARMACEUTICALS INC
Mar 10, 2026
Award(A)
Direct
136.6K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 24, 2026
Sale(S)
Direct
11.2K shares at avg. $3.66$41K
IRWD
IRONWOOD PHARMACEUTICALS INC
Feb 23, 2026
Sale(S)
Direct
10.3K shares at avg. $3.81$39K
IRWD
IRONWOOD PHARMACEUTICALS INC
Nov 17, 2025
Sale(S)
Direct
6K shares at avg. $3.32$20K
IRWD
IRONWOOD PHARMACEUTICALS INC
Aug 11, 2025
Sale(S)
Direct
1.3K shares at avg. $0.84$1K
IRWD
IRONWOOD PHARMACEUTICALS INC
May 16, 2025
Sale(S)
Direct
2.6K shares at avg. $0.58$1K

		Type	Shares	Price		Ownership
Mar 10, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	136,612	-	$0	Direct
Feb 24, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	11,239	$3.66	$41,135	Direct
Feb 23, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	10,287	$3.81	$39,193	Direct
Nov 17, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	6,016	$3.32	$19,973	Direct
Aug 11, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	1,316	$0.84	$1,105	Direct
May 16, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	2,563	$0.58	$1,487	Direct

1-6 of 6 transactions

About Gaskins Tammi L

Gaskins Tammi L (SEC CIK 0002061679) files insider reports with the SEC as Chief Commercial Officer of IRONWOOD PHARMACEUTICALS INC (IRWD).

Signal8 holds 6 ownership filings by Gaskins Tammi L (1 Form 3, 5 Form 4), filed between Mar 21, 2025 and Mar 12, 2026. Those filings report 6 transactions, from May 16, 2025 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gaskins Tammi L's filings is in BOSTON, MA.

Recent filings by Gaskins Tammi L

Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).
Nov 17, 2025: Open-market sale of IRWD shares (Form 4, code S).
Aug 11, 2025: Open-market sale of IRWD shares (Form 4, code S).

Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)

DENNER ALEXANDER J, Director
Silber Jeffrey, SVP, CMO, Head-Res&Drug
Silver Ronald, PFO & PAO
Shepard Jay, Director
Kessler Marla L, Director
Currie Mark G, Director

How to read Form 4 transaction codes